Baseline heart rate Z-score is associated with early RPP trajectory during dexmedetomidine-sufentanil sedation after pediatric transcatheter closure

儿童经导管封堵术后,使用右美托咪定-舒芬太尼镇静期间,基线心率Z评分与早期RPP轨迹相关。

阅读:2

Abstract

BACKGROUND: Dexmedetomidine (DEX) plus sufentanil (SF) sedation is commonly used after transcatheter closure for simple congenital heart disease (CHD), yet early hemodynamic responses vary. Absolute heart rate (HR) values are not comparable across pediatric ages; an age-standardized HR Z-score may better contextualize baseline HR status. OBJECTIVE: To evaluate the association between baseline HR Z-score and early postoperative trajectories of rate-pressure product (RPP), HR, and mean arterial pressure (MAP) under a standardized DEX + SF pathway, and to describe safety outcomes. METHODS: We retrospectively studied 96 children (0-16 years) admitted to the PICU after transcatheter closure (June 2023-August 2025). Hemodynamics were recorded at admission (T0), 1 h, 4 h, and 8 h. Longitudinal associations were assessed using linear mixed models including time, HR Z-score, and a time × Z-score interaction, with age as a covariate, with sensitivity analyses. RESULTS: RPP decreased over time and showed a significant time × HR Z-score interaction, indicating that baseline HR Z-score modified the early postoperative RPP trajectory. The corresponding interaction was significant for HR but not for systolic blood pressure or MAP, consistent with HR-driven differences, while SBP/MAP interactions were not statistically significant in this cohort. Bradycardia occurred in 9/96 patients (9.4%), and no hypotension events were observed. CONCLUSION: Baseline HR Z-score, as an approximate age-standardized index of heart rate, is associated with early postoperative myocardial workload trajectory after transcatheter closure under DEX + SF sedation, primarily via HR reduction, and may help guide monitoring intensity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。